TY - JOUR
T1 - Inflammatory bowel disease
T2 - Risk factors for adverse pregnancy outcome and the impact of maternal weight gain
AU - Oron, Galia
AU - Yogev, Yariv
AU - Shkolnik, Smadar
AU - Hod, Moshe
AU - Fraser, Gerald
AU - Wiznitzer, Arnon
AU - Melamed, Nir
PY - 2012/11
Y1 - 2012/11
N2 - Objective: To identify risk factors for adverse pregnancy outcome in women with inflammatory bowel disease (IBD) and to assess the effect of maternal pre-pregnancy weight and weight gain during pregnancy on pregnancy outcome. Methods: A retrospective, matched control study of all gravid women with IBD treated in a single tertiary center. Data were compared with healthy controls matched to by age, parity and pre-pregnancy BMI in a 3:1 ratio. Results: Overall, 300 women were enrolled, 75 women in the study group (28 with ulcerative colitis and 47 with Crohn's disease) and 225 in the control group. The rates of preterm delivery and small for gestational age were higher in the study group (13.3 vs. 5.3% p = 0.02 and 6.7 vs. 0.9%, p = 0.004). The rate of cesarean section (36 vs. 19.1%; p = 0.002), NICU admission (10.7 vs. 4.0%, p = 0.03) and low 5-Min Apgar (4.0 vs. 0.4%, p = 0.02) were increased in the study group. Disease activity within 3 months of conception [OR 8.4 (1.316.3)] and maternal weight gain of less than 12 kg. [OR 3.6 (1.112.2)] were associated with adverse pregnancy outcome. Conclusion: Active disease at conception and inappropriate weight gain during pregnancy are associated with increased adverse pregnancy outcome in patients with IBD.
AB - Objective: To identify risk factors for adverse pregnancy outcome in women with inflammatory bowel disease (IBD) and to assess the effect of maternal pre-pregnancy weight and weight gain during pregnancy on pregnancy outcome. Methods: A retrospective, matched control study of all gravid women with IBD treated in a single tertiary center. Data were compared with healthy controls matched to by age, parity and pre-pregnancy BMI in a 3:1 ratio. Results: Overall, 300 women were enrolled, 75 women in the study group (28 with ulcerative colitis and 47 with Crohn's disease) and 225 in the control group. The rates of preterm delivery and small for gestational age were higher in the study group (13.3 vs. 5.3% p = 0.02 and 6.7 vs. 0.9%, p = 0.004). The rate of cesarean section (36 vs. 19.1%; p = 0.002), NICU admission (10.7 vs. 4.0%, p = 0.03) and low 5-Min Apgar (4.0 vs. 0.4%, p = 0.02) were increased in the study group. Disease activity within 3 months of conception [OR 8.4 (1.316.3)] and maternal weight gain of less than 12 kg. [OR 3.6 (1.112.2)] were associated with adverse pregnancy outcome. Conclusion: Active disease at conception and inappropriate weight gain during pregnancy are associated with increased adverse pregnancy outcome in patients with IBD.
KW - Complication
KW - Inflammatory bowel disease
KW - Pregnancy
KW - Weight gain
UR - http://www.scopus.com/inward/record.url?scp=84867499432&partnerID=8YFLogxK
U2 - 10.3109/14767058.2012.684176
DO - 10.3109/14767058.2012.684176
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84867499432
SN - 1476-7058
VL - 25
SP - 2256
EP - 2260
JO - Journal of Maternal-Fetal and Neonatal Medicine
JF - Journal of Maternal-Fetal and Neonatal Medicine
IS - 11
ER -